Aurora Private Equity
16
8M
8
0.89
5
0.20
2
- Stages of investment
- Areas of investment
Summary
Aurora Private Equity is the famous VC, which was founded in 2003. The main department of described VC is located in the Aberdeen. The company was established in Europe in United Kingdom.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Aurora Private Equity, startups are often financed by Intersouth Partners, The Aurora Funds, TVM Capital. The meaningful sponsors for the fund in investment in the same round are Triangle Venture Capital Group, Sino-Ocean Capital, Qianbao.com. In the next rounds fund is usually obtained by Woodford Investment Management, yet2Ventures, Pharmstandard.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. Considering the real fund results, this VC is 37 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2007. This Aurora Private Equity works on 0 percentage points less the average amount of lead investments comparing to the other organizations.
We also calculated 3 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight FineEx, Cytosystems, NovaBiotics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are E-Commerce, Hospital. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 5
- Exits
- 2
- Rounds per year
- 0.89
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (6)
- Medical (4)
- Health Care (4)
- Therapeutics (3)
- Clinical Trials (2) Show 13 more
- Investments by region
-
- China (3)
- United States (1)
- United Kingdom (6)
- Ireland (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.53
- Avg. company exit year
- 96
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NovaBiotics | 01 Jun 2009 | Biotechnology, Medical, Therapeutics, Clinical Trials | Seed | 1M | Scotland, Aberdeen, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.